C 31G

10/01/2013 - "C31G and TFT were very effective in reducing the lesions and pathogenesis associated with HSV-1 ocular keratitis. "
10/01/2013 - "No previous in vivo studies have been done to test C31G in an animal model of HSV-1 ocular keratitis. "
10/01/2013 - "The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model."

07/01/2014 - "Gargling with C31G or Sense-Time would enhance oropharyngeal hygiene, which would be helpful for reducing influenza transmission. "

09/01/1998 - "The 12th World AIDS Conference exhibited presentations on the safety and efficacy of microbicide products currently in development, including: Pro-2000 (Procept), BufferGel ( ReProtect), Protectaid (Biopharm Laboratories), and C31G (Biosyn). "

01/23/2008 - "The objective of this trial was to determine the effectiveness of 1.0% C31G (SAVVY) in preventing male-to-female vaginal transmission of HIV infection among women at high risk. "
12/19/2007 - "The objective of this trial was to determine the effectiveness of 1.0% C31G (SAVVY) in preventing male-to-female vaginal transmission of HIV infection among women at high risk. "
12/19/2007 - "SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana."
01/23/2008 - "SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria."
02/01/2004 - "Glyminox (Savvy) is a vaginal gel formulation of C31G being developed by Biosyn as a potential contraceptive and for the potential prevention of transmission of sexually transmitted diseases, including HIV infection. "

07/01/1983 - "In this animal model, histologic features of wounds treated topically with C31G revealed an increased rate of wound closure associated with decreased inflammatory response and increased C31G fibroblast infiltration and epithelialization. "
01/01/1986 - "Alcide-treated wounds incorporated less than 50% of the amount of 14C-proline than did the wounds treated with C31G. "
01/01/1986 - "At 7, 10, and 16 days after surgery, tensiometric measurements of C31G (a surfactant)-treated wounds were 99%, 139%, and 195% of control wound values, respectively. "
07/01/1983 - "An anti-infective surfactant composition (C31G) promoted healing of infected and noninfected wounds in guinea pigs. "
07/01/1983 - "Effect of C31G, an antimicrobial surfactant, on healing of incised guinea pig wounds."